Pfizer India launches free-of-cost online education platform on AMR for nurses Ruchika Sharma11 Jun 2022 12:26 PM ISTThe classes are available for all nurses, at different designations and levels of education and professional experience, from students to...
Pfizer Myfembree sNDA accepted by USFDA for review Ruchika Sharma6 Jun 2022 2:15 PM ISTMYFEMBREE was approved in the U.S. in 2021 for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women with...
Pfizer appoints Annaliesa Anderson as Senior Vice President Ruchika Sharma4 Jun 2022 4:52 PM ISTNew York: Pfizer Inc. has announced that Annaliesa Anderson, Ph.D., has been appointed Senior Vice President and Head of the Company's Vaccine...
Study says Pfizer COVID drug Paxlovid reduces COVID risk in seniors regardless of vaccine status Ruchika Sharma3 Jun 2022 1:17 PM ISTPfizer's clinical trial tested Paxlovid in unvaccinated people who had risk factors for serious disease and found that the two-drug treatment cut the...
Pfizer-BioNTech seeks USFDA authorisation for COVID vaccine for kids under 5 years Ruchika Sharma3 Jun 2022 11:30 AM ISTNo COVID-19 shot is yet approved for children in that age group in most parts of the world.
Pfizer plans to exit 32 percent stake in GSK JV Haleon after demerger Ruchika Sharma2 Jun 2022 1:14 PM ISTBefore the spinoff, the holding company for Haleon will pay dividends to GSK and Pfizer. GSK said it would receive cash proceeds of more than 7...
Pfizer-BioNTech COVID booster authorized in Canada for 16, 17-year-olds Ruchika Sharma2 Jun 2022 10:00 AM ISTThe agency said potential risks of inflammatory heart conditions, myocarditis or pericarditis, have been included in the shot's label.
Pfizer gets USFDA Fast Track Designation for Ervogastat plus Clesacostat to treat NASH Ruchika Sharma28 May 2022 11:57 AM ISTDiacylglycerol O-acyltransferase 2 (DGAT2) and acetyl-CoA carboxylase (ACC) are two key enzymes that regulate lipid metabolism. Inhibitors of ACC and...
Pfizer third COVID vaccine shot over 80 percent effective against Omicron in kids under 5 MD Bureau24 May 2022 3:55 PM ISTStudies in adults, adolescents, and children over 5 years of age continue to indicate that three doses of the Pfizer-BioNTech COVID-19 Vaccine...
Pfizer-BioNTech COVID booster shot gets USFDA emergency use nod for children aged 5 to 11 Ruchika Sharma18 May 2022 11:48 AM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Health Bulletin 17/May/2022 Isra Zaman17 May 2022 4:40 PM ISTHere are the top health stories for the day: Entry level Ayush NABH certificates given to 5 Ayurveda Hospitals Ministry of Ayush has...
USFDA to soon authorize Pfizer COVID booster shot for children aged 5 to 11: NYT Ruchika Sharma17 May 2022 11:00 AM ISTThey have cited data from a mid- to late-stage study showing a third dose of their shot increased protection against the original coronavirus version...
